Spots Global Cancer Trial Database for her2 negative breast carcinoma expressing cea
Every month we try and update this database with for her2 negative breast carcinoma expressing cea cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA | NCT01730612 | HER2 Negative B... | TF2 - 68 Ga-IMP... | 18 Years - | Nantes University Hospital |